Navigation Links
Bioinformatics Pioneer Robert Gentleman, Ph.D., Joins 23andMe Leadership Team
Date:4/2/2015

MOUNTAIN VIEW, Calif., April 2, 2015 /PRNewswire/ -- 23andMe, Inc., the leading personal genetics company, today announced the appointment of Robert Gentleman, Ph.D., as vice president of computational biology. Dr. Gentleman joins 23andMe to focus on the exploration of how the human genetic and trait data in the 23andMe database can be used to identify new therapies for disease. Most recently, Dr. Gentleman served as senior director of bioinformatics and computational biology at Genentech.

"Dr. Gentleman is a trailblazer in his field," said Andy Page, president, 23andMe. "A scientist of his caliber coming to the company speaks volumes about the rigorous scientific foundation 23andMe has built and the unique opportunity our data set provides to identify significant genetic discoveries."

In addition to broadly overseeing computational biology activities at the company, Dr. Gentleman will specifically focus on collaborating with Dr. Richard Scheller, 23andMe chief science officer and head of therapeutics. He will work with Dr. Scheller and others to help the newly formed therapeutics group utilize data analytics and theoretical models to identify trends and ultimately advance the drug research and discovery process.

"My hope is that my experience can help bring better treatments to market fast for the patients who need them most," said Dr. Gentleman.  "I'm excited to have the opportunity to work with the 23andMe community so we can together find these great cures.  It is the commitment of the active 23andMe research community that enables this potentially groundbreaking venture."

Dr. Gentleman's career has spanned more than 30 years.  Prior to joining Genentech, Dr. Gentleman was a member of the Fred Hutchinson Cancer Research Center, where he was the head of the computational biology department.  Dr. Gentleman served as a professor at Harvard University, the University of Auckland, and the University of Waterloo. During his tenure at Harvard, Dr. Gentleman founded the Bioconductor Project, an open source, open development software project to provide tools for the analysis and comprehension of high-throughput genomic data.

In addition to his industry and academic experience, Dr. Gentleman recently served as member of the board of directors of Revolution Analytics where he helped guide the company through a successful acquisition by Microsoft. He has been awarded the Benjamin Franklin Award, an award for Open Access in the Life Sciences presented by the Bioinformatics Organization and is Fellow of the International Society for Computational Biology (ISCB).  Dr. Gentleman, along with Ross Ihaka at the University of Auckland, is also recognized as one of the originators of the R programming language, a widely-used programming language software environment for statistical computing and graphics.

Dr. Gentleman earned a Bachelor of Science in mathematics from The University of British Columbia and holds a Doctor of Philosophy, Ph.D., in statistics from the University of Washington.

23andMe is actively hiring in a variety of areas, particularly for computational biologists, geneticists, interaction designers and software test engineers. For more information on available positions please visit www.23andme.com/careers.

About 23andMe

23andMe, Inc. is the leading personal genetics company. Founded in 2006, the mission of the company is to help people access, understand and benefit from the human genome. 23andMe has over 900,000 customers worldwide with over 80 percent consented to participate in research. 23andMe, Inc. is located in Mountain View, CA. More information is available at www.23andMe.com.


'/>"/>
SOURCE 23andMe, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. BioInformatics LLC Announces New Market Report – Enhancing the Customer Experience: Insights and Life Science Supplier Rankings (13-002)
2. Life Technologies Launches New Bioinformatics Software Platform Enabling Bio-Design and Gene Synthesis from Next Generation Sequencing Data
3. Japan Bioinformatics Announces Release of a Case Study on Detecting SNPs and Short INDELs
4. Bioinformatics: Technologies and Global Markets
5. BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004)
6. Bioinformatics Market Worth $7.5 Billion by 2017
7. BioInformatics, LLC New Market Research Report – Life Science Instruments: Brand Performance
8. BioInformatics LLC—New Report Finds High Degree of Satisfaction With Instrumentation Performance Among Researchers
9. BioInformatics, LLC Deploys RateMyProduct™ to Rate Benchtop Real-time PCR Machines
10. BioInformatics LLC [Webcast] – RateMyProduct™: Find Out Why Life Science Suppliers Are Using It, August 14, 2013
11. India Bioinformatics Industry Market Size Expected to Grow by Average Annual Growth of 14.4% in the Next 5 Years: Ken Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced the ... NIH to develop RealSeq®-SC (Single Cell), expected to be ... small RNAs (including microRNAs) from single cells using NGS ... the need to accelerate development of approaches to analyze ... "New techniques for measuring levels of mRNAs ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program ... honoring scientists who have made outstanding contributions to analytical chemistry and ... 2018, the world’s leading conference and exposition for laboratory science, which will be ...
(Date:10/9/2017)... ... , ... The award-winning American Farmer television series will feature 3 Bar Biologics ... at 8:30aET on RFD-TV. , With global population estimates nearing ten billion people ... to feed a growing nation. At the same time, many of our valuable resources ...
(Date:10/9/2017)... ... October 09, 2017 , ... The ... medical marijuana products targeting the needs of consumers who are incorporating medical marijuana ... place in Phoenix, Arizona. , As operators of two successful Valley dispensaries, The ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
Breaking Biology News(10 mins):